Stocks
Arrowhead Pharmaceuticals (ARWR) EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA, bln rub | ? | -132.6 | -162.3 | -175.7 | -561.5 | 164.8 | -134.5 | |
| Changes by years, y/y, % | +52% | +22% | +8% | +220% | -129% | |||
Arrowhead Pharmaceuticals. EBITDA US GAAP, bln rub
Arrowhead Pharmaceuticals. EBITDA US GAAP, changes, %
Arrowhead Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Arrowhead Pharmaceuticals (ARWR) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 397.3 | -148.5 | 64.2 | 57.2 | -107.4 | -134.5 | |
| Changes by years, y/y, % | -445% | -10% | -142% | -139% | -127% | |||
| Changes by quarters, q/q, % | -368% | -137% | -143% | -11% | -288% | |||
